Abstract:HIV-1 protease (PR) plays a crucial role in the treatment of HIV as a key target. The emergence of drug resistance remains a growing global problem, and mutations in PR constitute a significant threat to the efficacy of small molecule inhibitors. HIV-1 PR is an ideal model for studying drug resistance to inhibitors. The inhibitor, Darunavir (DRV), has a high genetic barrier to viral resistance, but with mutations of residues in the PR, there is also some resistance to DRV. There are two types of inhibition of PR by inhibitors. One type involves binding to the active site of the dimerization protease, while the other involves binding to the PR monomer, thereby preventing dimerization. In the present study, we aimed to investigate the inhibitory effect of DRV with a modified inhibitor on PR, comparing the differences between wild-type and mutated PR, using molecular dynamics simulations. The inhibitory effect of the inhibitors on PR monomers was subsequently investigated. And molecular mechanics Poisson-Boltzmann surface area evaluated the binding free energy. The energy contribution of individual residues in the complex was accurately calculated by the alanine scanning binding interaction entropy method. The results showed these inhibitors had strong inhibitory effects against PR mutations, with GRL-142 exhibiting potent inhibition of both PR monomer and dimer. The improvement of the inhibitors could form stronger hydrogen-bond between inhibitor and PR, and electrostatic interactions, leading to the enhanced inhibition effect. The binding of the inhibitor and mutation of the PR affected the distance between D25 and I50, preventing their dimerization and the development of drug resistance. This study could accelerate research targeting HIV-1 PR inhibitors and help further facilitate drug design targeting both mechanisms.

Insight into binding mechanisms of inhibitors MKP56, MKP73, MKP86, and MKP97 to HIV-1 protease by using molecular dynamics simulation

Identifying the Molecular Mechanics and Binding Dynamics Characteristics of Potent Inhibitors to HIV‐1 Protease

Some Insights into Mechanism for Binding and Drug Resistance of Wild Type and I50V V82A and I84V Mutations in HIV-1 Protease with GRL-98065 Inhibitor from Molecular Dynamic Simulations.

Effect of Polarization on HIV-1protease and Fluoro-Substituted Inhibitors Binding Energies by Large Scale Molecular Dynamics Simulations

Exploring Drug-Resistant Mechanisms of I84V Mutation in HIV-1 Protease Toward Different Inhibitors by Thermodynamics Integration and Solvated Interaction Energy Method

Binding Kinetics Study of SARS-CoV-2 Main Protease and Potential Inhibitors Via Molecular Dynamics Simulations.

Coarse-grained Molecular Dynamics of Inhibitors Binding into HIV-1 Protease

Study The Interaction Between The HIV-1 Protease and Its Mutations With Inhibitor GRL-0519 by The Computational Method

Multiple Molecular Dynamics Simulations and Free-Energy Predictions Uncover the Susceptibility of Variants of HIV-1 Protease against Inhibitors Darunavir and KNI-1657

Evaluation of Novel HIV-1 Protease Inhibitors with DRV-resistance by Utilizing 3D-QSAR Molecular Docking and Molecular Dynamics Simulation

Coarse-Grained Molecular Dynamics Of Ligands Binding Into Protein: The Case Of Hiv-1 Protease Inhibitors

Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis

A Comparative Insight into Amprenavir Resistance of Mutations V32i, G48v, I50v, I54v, and I84v in Hiv-1 Protease Based on Thermodynamic Integration and Mm-Pbsa Methods

Quantum mechanical analysis of newly synthesized HIV-1 protease inhibitors: evaluation of wild-type and resistant strain binding interactions

Binding Modes and Conformational Changes of FK506-binding Protein 51 Induced by Inhibitor Bindings: Insight into Molecular Mechanisms Based on Multiple Simulation Technologies

Advanced Molecular Mechanisms of Modified DRV Compounds in Targeting HIV-1 Protease Mutations and Interrupting Monomer Dimerization

Multiple Molecular Dynamics Simulations and Energy Analysis Unravel the Dynamic Properties and Binding Mechanism of Mutants HIV-1 Protease with DRV and CA-p2

Molecular Modeling Evaluation of the Binding Effect of Five Protease Inhibitors to COVID-19 Main Protease.

Revealing Origin Of Decrease In Potency Of Darunavir And Amprenavir Against Hiv-2 Relative To Hiv-1 Protease By Molecular Dynamics Simulations

Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations

Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H.